Track topics on Twitter Track topics that are important to you
Kalypsys, Inc. is a biopharmaceutical company pioneering an industrialized approach to pathway-based drug discovery. Kalypsys implements discovery programs across a broad number of therapeutic areas using its highly automated and integrated suite of discovery technologies in biology, chemistry and informatics. By using a pathway-based discovery strategy together with these integrated technologies, Kalypsys is able to significantly improve the efficiency and productivity of drug discovery.
Kalypsys is based on pathway-based drug discovery technologies and chemical optimization technologies from the Genomics Institute of the Novartis Research Foundation (GNF); these integrated technologies span much of the drug discovery process, and were developed by over a hundred biologists, chemists and engineers at the GNF over the past two and one half years. Kalypsys uses these core technologies to carry out an information-intensive approach to pharmaceutical drug discovery. The net result of this information-intensive pathway-based discovery strategy is that Kalypsys is able to make better decisions earlier in the development process, improving the probability of success, quality, and productivity of drug discovery.
11099 North Torrey Pines Road
United States of America
SAN DIEGO, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced the pricing of its underwritten public offering of 14,285,714 shares of common stock or common stock ...
PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...
Founded in 2008 by the Axis Biotec Brasilâ¢ group (www.axisbiotec.com.br), PharmaPraxis has incorporated technologies, and will develop and launch biologic products in Brazil....
COOK SIS is sold under various brand names to treat a wide range of conditions including management of dermal wounds and burns, reinforcement of many types of weakened tissue, and treatment of urinary...
Kalypsys, Inc. is a biopharmaceutical company pioneering an industrialized approach to pathway-based drug discovery. Kalypsys implements discovery programs across a broad number of therapeutic areas u...
Founded by Conrad Kenley in 1990, LCG, Inc. is a leader in providing grants management solutions to health and social services agencies. LCG Systems (a subsidiary of LCG, Inc.) ...
We have published hundreds of Kalypses Incorporated news stories on BioPortfolio along with dozens of Kalypses Incorporated Clinical Trials and PubMed Articles about Kalypses Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Kalypses Incorporated Companies in our database. You can also find out about relevant Kalypses Incorporated Drugs and Medications on this site too.
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...